| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Pathology, University of Massachusetts Medical Center, Worcester, MA 01655;
Department of Pathology, University of Texas, Southwestern, Dallas, TX; and
Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, MD
The distributions and functions of NK cell subsets, as
defined by the expression of Ly49 NK cell receptors, were examined in
murine CMV (MCMV)-infected mice. MCMV induced a reduction in
NK1.1+ cell number in the spleen and an increase in the
peritoneal exudate cells. Within the splenic NK1.1+
population, proportional increases in Ly49A+ and
Ly49G2+ cells but decreases in Ly49C+ and
Ly49D+ cells were observed 3 days post-MCMV infection, but
within the peritoneal NK1.1+ cell populations there were
proportional decreases in Ly49A+ cells and increases in
Ly49C+, Ly49D+, and Ly49G2+ cells.
Lymphocytic choriomeningitis virus did not elicit a comparable NK cell
subset distribution. Lymphokine-activated killer cells were sorted into
different Ly49 NK cell subsets and adoptively transferred into C57BL/6
suckling mice. Regulation of MCMV synthesis in these suckling mice was
shown to be an IFN-
-dependent, perforin- and
Cmv-1-independent process, and each NK cell subset
mediated anti-viral activity. In adult C57BL/6 mice, the control of
MCMV in the spleen is mediated by a perforin-dependent mechanism,
regulated in part by the Cmv-1 gene, which maps closely
to the Ly49 family. In vivo depletions of either one or two of the Ly49
subsets in adult mice did not affect the ability of the residual NK
cells to regulate MCMV synthesis. These data provide evidence of NK
cell subset distribution and function in MCMV infection, but no
individual subset was required for the Cmv-1-like
regulation of MCMV synthesis.
This article has been cited by other articles:
|
|
 |
|
  X. Xie, M. D. Stadnisky, and M. G. Brown MHC Class I Dk Locus and Ly49G2+ NK Cells Confer H-2k Resistance to Murine Cytomegalovirus J. Immunol., June 1, 2009; 182(11): 7163 - 7171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Winkler-Pickett, H. A. Young, J. M. Cherry, J. Diehl, J. Wine, T. Back, W. E. Bere, A. T. Mason, and J. R. Ortaldo In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses J. Immunol., April 1, 2008; 180(7): 4495 - 4506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Loh, D. T. Chu, A. K. O'Guin, W. M. Yokoyama, and H. W. Virgin IV Natural Killer Cells Utilize both Perforin and Gamma Interferon To Regulate Murine Cytomegalovirus Infection in the Spleen and Liver J. Virol., January 1, 2005; 79(1): 661 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Warfield, J. G. Perkins, D. L. Swenson, E. M. Deal, C. M. Bosio, M. J. Aman, W. M. Yokoyama, H. A. Young, and S. Bavari Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection J. Exp. Med., July 19, 2004; 200(2): 169 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Makrigiannis, E. Rousselle, and S. K. Anderson Independent Control of Ly49g Alleles: Implications for NK Cell Repertoire Selection and Tumor Cell Killing J. Immunol., February 1, 2004; 172(3): 1414 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inngjerdingen, B. Rolstad, and J. C. Ryan Activating and Inhibitory Ly49 Receptors Modulate NK Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 10 and CXCL12 J. Immunol., September 15, 2003; 171(6): 2889 - 2895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Falk, M. Mach, D. J. Schendel, E. H. Weiss, I. Hilgert, and G. Hahn NK Cell Activity During Human Cytomegalovirus Infection Is Dominated by US2-11-Mediated HLA Class I Down-Regulation J. Immunol., September 15, 2002; 169(6): 3257 - 3266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Korten, L. Volkmann, M. Saeftel, K. Fischer, M. Taniguchi, B. Fleischer, and A. Hoerauf Expansion of NK Cells with Reduction of Their Inhibitory Ly-49A, Ly-49C, and Ly-49G2 Receptor-Expressing Subsets in a Murine Helminth Infection: Contribution to Parasite Control J. Immunol., May 15, 2002; 168(10): 5199 - 5206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Robbins, K. B. Nguyen, N. Takahashi, T. Mikayama, C. A. Biron, and L. Brossay Cutting Edge: Inhibitory Functions of the Killer Cell Lectin-Like Receptor G1 Molecule During the Activation of Mouse NK Cells J. Immunol., March 15, 2002; 168(6): 2585 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Topham, R. C. Cardin, J. P. Christensen, J. W. Brooks, G. T. Belz, and P. C. Doherty Perforin and Fas in murine gammaherpesvirus-specific CD8+ T cell control and morbidity J. Gen. Virol., August 1, 2001; 82(8): 1971 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Daniels, G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh Murine Cytomegalovirus Is Regulated by a Discrete Subset of Natural Killer Cells Reactive with Monoclonal Antibody to Ly49H J. Exp. Med., June 25, 2001; 194(1): 29 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Brown, A. O. Dokun, J. W. Heusel, H. R. C. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection Science, May 4, 2001; 292(5518): 934 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Presti, D. L. Popkin, M. Connick, S. Paetzold, and H. W. Virgin , IV Novel Cell Type-specific Antiviral Mechanism of Interferon {{gamma}} Action in Macrophages J. Exp. Med., February 20, 2001; 193(4): 483 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goodbourn, L. Didcock, and R. E. Randall Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures J. Gen. Virol., October 1, 2000; 81(10): 2341 - 2364. [Full Text]
|
|
|
|
|
|
L. L. Wang, D. T. Chu, A. O. Dokun, and W. M. Yokoyama Inducible Expression of the gp49B Inhibitory Receptor on NK Cells J. Immunol., May 15, 2000; 164(10): 5215 - 5220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Depatie, A. Chalifour, C. Pare, S.-H. Lee, S. M. Vidal, and S. Lemieux3 Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets Int. Immunol., September 1, 1999; 11(9): 1541 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sjolin, E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni Pivotal Role of KARAP/DAP12 Adaptor Molecule in the Natural Killer Cell-mediated Resistance to Murine Cytomegalovirus Infection J. Exp. Med., March 25, 2002; 195(7): 825 - 834. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
